Merck KGaA Stock

Merck KGaA Net Income 2024

Merck KGaA Net Income

1.14 B EUR

Ticker

MRK.DE

ISIN

DE0006599905

WKN

659990

In 2024, Merck KGaA's profit amounted to 1.14 B EUR, a -59.64% increase from the 2.82 B EUR profit recorded in the previous year.

The Merck KGaA Net Income history

YEARNET INCOME (undefined EUR)
2029e1.67
2028e1.6
2027e1.48
2026e1.38
2025e1.28
2024e1.14
20232.82
20223.33
20213.06
20201.99
20191.32
20183.37
20172.61
20161.63
20151.11
20141.16
20131.2
20120.57
20110.62
20100.63
20090.37
20080.37
20073.5
20060.98
20050.66
20040.66

Merck KGaA Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Merck KGaA, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Merck KGaA from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Merck KGaA’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Merck KGaA. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Merck KGaA’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Merck KGaA’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Merck KGaA’s growth potential.

Merck KGaA Revenue, EBIT and net profit per share

DateMerck KGaA RevenueMerck KGaA EBITMerck KGaA Net Income
2029e26.03 B undefined0 undefined1.67 B undefined
2028e26.29 B undefined6.3 B undefined1.6 B undefined
2027e25.4 B undefined5.83 B undefined1.48 B undefined
2026e23.47 B undefined5.63 B undefined1.38 B undefined
2025e22.56 B undefined5.14 B undefined1.28 B undefined
2024e21.53 B undefined4.15 B undefined1.14 B undefined
202320.99 B undefined4.22 B undefined2.82 B undefined
202222.23 B undefined5.26 B undefined3.33 B undefined
202119.69 B undefined4.36 B undefined3.06 B undefined
202017.53 B undefined3.07 B undefined1.99 B undefined
201916.15 B undefined2.51 B undefined1.32 B undefined
201814.84 B undefined2.13 B undefined3.37 B undefined
201714.52 B undefined2.4 B undefined2.61 B undefined
201615.02 B undefined2.49 B undefined1.63 B undefined
201512.84 B undefined2.24 B undefined1.11 B undefined
201411.36 B undefined1.84 B undefined1.16 B undefined
201311.1 B undefined2.14 B undefined1.2 B undefined
201211.17 B undefined1.89 B undefined567 M undefined
201110.28 B undefined1.42 B undefined618 M undefined
20109.29 B undefined1.4 B undefined632 M undefined
20097.75 B undefined870 M undefined366 M undefined
20087.56 B undefined1.19 B undefined367 M undefined
20077.06 B undefined1.24 B undefined3.5 B undefined
20066.28 B undefined1.11 B undefined983 M undefined
20055.97 B undefined882 M undefined659 M undefined
20045.47 B undefined748 M undefined659 M undefined

Merck KGaA stock margins

The Merck KGaA margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Merck KGaA. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Merck KGaA.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Merck KGaA's sales revenue. A higher gross margin percentage indicates that the Merck KGaA retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Merck KGaA's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Merck KGaA's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Merck KGaA's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Merck KGaA. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Merck KGaA's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Merck KGaA Margin History

Merck KGaA Gross marginMerck KGaA Profit marginMerck KGaA EBIT marginMerck KGaA Profit margin
2029e60.13 %0 %6.42 %
2028e60.13 %23.94 %6.08 %
2027e60.13 %22.96 %5.84 %
2026e60.13 %23.98 %5.86 %
2025e60.13 %22.8 %5.67 %
2024e60.13 %19.26 %5.29 %
202360.13 %20.11 %13.45 %
202262.16 %23.64 %14.96 %
202162.79 %22.17 %15.52 %
202061.32 %17.51 %11.33 %
201963.16 %15.53 %8.17 %
201863.99 %14.34 %22.74 %
201765.07 %16.53 %17.94 %
201665.38 %16.59 %10.84 %
201568.26 %17.47 %8.68 %
201468.97 %16.16 %10.18 %
201373.03 %19.25 %10.83 %
201271.74 %16.92 %5.07 %
201172.87 %13.82 %6.01 %
201074.32 %15.1 %6.8 %
200973.81 %11.23 %4.72 %
200874.78 %15.71 %4.86 %
200774.78 %17.59 %49.6 %
200661.58 %17.6 %15.64 %
200560.3 %14.78 %11.04 %
200458.91 %13.66 %12.04 %

Merck KGaA Aktienanalyse

What does Merck KGaA do?

Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Merck KGaA revenue by segment

In the annual report of the Merck KGaA share (DE0006599905, 659990, MRK.DE), it breaks down its revenues into 3 segments: 1. Life Science, 2. Healthcare, 3. Performance Materials. The Merck KGaA stock (WKN: 659990, ISIN: DE0006599905, Ticker Symbol: MRK.DE) is a leading investment for investors interested in participating in the Health Care sector.

  • 42 % Life Science

  • 42 % Healthcare

  • 16 % Performance Materials

Net Income Details

Understanding Merck KGaA's Profit Margins

The profit margins of Merck KGaA represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Merck KGaA's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Merck KGaA's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Merck KGaA's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Merck KGaA’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Merck KGaA stock

How much profit has Merck KGaA made this year?

Merck KGaA has made 1.14 B EUR this year.

How has the profit developed compared to last year?

The profit has increased by -59.64% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Merck KGaA publish its earnings?

Merck KGaA publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Merck KGaA?

The profits of Merck KGaA are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Merck KGaA?

You can learn more about the earnings of Merck KGaA by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Merck KGaA pay?

Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.43 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.

What is the dividend yield of Merck KGaA?

The current dividend yield of Merck KGaA is 1.43 %.

When does Merck KGaA pay dividends?

Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.

How secure is the dividend of Merck KGaA?

Merck KGaA paid dividends every year for the past 26 years.

What is the dividend of Merck KGaA?

For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.57 %.

In which sector is Merck KGaA located?

Merck KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Merck KGaA pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Merck KGaA in the year 2023?

In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.

In which currency does Merck KGaA pay out the dividend?

The dividends of Merck KGaA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Merck KGaA

Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.